Skip to content
Kalpvruksh Markets
Offline Log in

ERISNSEOffline

ERIS LIFESCIENCES · INE406M01024 · Small Cap · #363
1,229.90+14.90 (+1.23%)last close · 05 Nov 2026
Prev close
1,215.00
Open
—
High
—
Low
—
Volume
—
Mkt cap (6-mo avg)
₹19,054 cr
52-week range · to 05 Nov 20261,095.51,701.3

Loading minute bars…

NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.

ERIS is 28% below its 52-week high, below its 200-day average — a Small Cap company, #363 by market cap.NSE prices to 05 Nov 2026 · a description of the data, not advice

Overview

What the data says, line by line

A description, never a buy or sell word · tap a line for its detail

  • above its 20-day average · below its 50 / 200-day averages · 28% below its 52-week high
  • −8.6% vs Nifty 500
  • traded value 1.1× usual · delivery 61% vs 55% usual
  • FPI −0.0 pp · DII −0.5 pp · MF schemes in Sept 2026: 7 bought, 42 cut · promoter pledge 21.3% · quarter ended 2026-09-30
  • nothing scheduled or restricting

How big is it?

six-month average market cap

Market capitalisation
₹19,054 cr
Rank
#363
Cap band
Small Cap
Nearest cut-off — Mid / Small
−44.27% from ₹34,190 cr
Clear of the cut-off

Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.

Did buyers take delivery?

latest session · 2026-11-05

vs its own normal
0.6×
median 77,314
Delivered
49,718
Of volume
65%

Price & trend

Returns

to 05 Nov 2026

PeriodStockvs Nifty 500vs its industry
1 week+5.7%−0.1 pts—
1 month+3.8%−0.8 pts—
3 months−10.6%−8.6 pts—
6 months−10.4%−10.7 pts—
1 year−24.1%−22.1 pts—

Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.

Averages & movement

vs 20-day average
+6.3%
above
vs 50-day average
−0.1%
below
vs 200-day average
−8.6%
below
ATR (14)
3.7%
typical daily range
Volatility
38%
1 month, annualised
Beta
0.69
vs Nifty 500, 1 year
Traded value
1.1×
vs usual
Delivery
61%
usual 55%
From the 52-week high
−27.7%
place in range 22% (0 = at the low)

Ownership

Who owns the company

% of all shares, by quarter

GroupDec 25Mar 26Jun 26Sep 26
Promoters54.9%53.9% −0.954.1% +0.254.7% +0.6
FPI6.8%6.4% −0.55.8% −0.65.7%
Mutual funds18.3%18.2%18.9% +0.718.0% −0.9
Other DII2.1%2.1% +0.11.8% −0.32.2% +0.4
Individuals8.5%10.1% +1.610.1%9.9% −0.2
Others9.5%9.3% −0.29.3%9.4% +0.1

From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.

Promoter pledge

Sep 26

Of promoters’ holding
21.3%
Of all shares
11.6%
Jun 25 16.9%Sep 25 16.9%Dec 25 16.9%Mar 26 16.9%Jun 26 16.9%Sep 26 21.3%

Holders

Sep 26

All shareholders
49,034
Individuals
46,312

Indian passive funds’ stake

2026-06-30

Of free float
0.50%
Of all shares
0.23%
Schemes
42
Days to unwind
1.7
at 100% of volume

3,19,525 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.

Which funds bought and sold

mutual funds · quarter ended 2026-06-30

Funds holding
94
42 index · 52 active
Bought more
41
Sold some
19
FundSharesChangeDid
Motilal Oswal Innovation Opportunities Fund-Reg(G)Active+1,08,311+810.3%bought
Bandhan Small Cap Fund-Reg(G)Active+1,36,408+31.5%bought
Mirae Asset Healthcare Fund-Reg(G)Active+1,50,238+26.5%bought
UTI ULIP(G)Active−45,341−40.4%sold
UTI Flexi Cap Fund-Reg(IDCW)Active−4,11,724−35.1%sold
HDFC Pharma and Healthcare Fund-Reg(G)Active−70,000−20.5%sold

Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.

Mutual-fund schemes, month by month

fund houses’ own monthly portfolios

MonthSchemesBought newAddedCutSold outShares heldValue
Sep 2657251131−0.9%₹2,864 cr
Aug 26861036611−3.5%₹3,145 cr
Jul 2687533145−1.4%₹3,405 cr
Jun 2687420285+0.0%₹3,653 cr
May 2688424170+0.6%₹3,563 cr
Apr 2684534111+2.0%₹3,349 cr

Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.

Fund ownership is a quarterly disclosure and counts Indian passive schemes only.

Results

Results

Events & filings

Disclosures & deals

last six months · NSE filings

  • Board outcome
    Eris Lifesciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
    26 Oct 2026
  • Board outcome
    Eris Lifesciences Limited has informed the Exchange regarding Outcome of Board Meeting held on August 31, 2026.
    31 Aug 2026
  • Board outcome
    Eris Lifesciences Limited has submitted to the Exchange, the financial results for the period ended June 30, 2026.
    29 Jul 2026
  • Board outcome
    Eris Lifesciences Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
    20 May 2026

ERIS: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.

Corporate actions

full published history

0 selected
EarlierDividend₹7.21Interim29 May 202629 May 2026
EarlierDividend₹7.35Interim13 Feb 202513 Feb 2025
EarlierDividend₹7.35Interim11 Aug 202216 Aug 2022

3 shown. A falling price on an ex-date is not a loss: a dividend leaves the share as cash and a bonus multiplies the shares held.

Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.